3-(2-Methyl-1,3-thiazol-4-yl)benzaldehyde → 6-(2,4-Dimethoxypyridin-3-yl)-1-(3-(2-methylthiazol-4-yl)benzyl)piperidin-2-one

HRID 594472노트

반응식

HRID 594472 반응식
[NH2:1][CH:2]([C:10]1[C:11]([O:18][CH3:19])=[N:12][CH:13]=[CH:14][C:15]=1[O:16][CH3:17])[CH2:3][CH2:4][CH2:5][C:6]([O:8]C)=O.[CH3:20][C:21]1[S:22][CH:23]=[C:24]([C:26]2[CH:27]=[C:28]([CH:31]=[CH:32][CH:33]=2)[CH:29]=O)[N:25]=1>>[CH3:19][O:18][C:11]1[C:10]([CH:2]2[N:1]([CH2:29][C:28]3[CH:31]=[CH:32][CH:33]=[C:26]([C:24]4[N:25]=[C:21]([CH3:20])[S:22][CH:23]=4)[CH:27]=3)[C:6](=[O:8])[CH2:5][CH2:4][CH2:3]2)=[C:15]([O:16][CH3:17])[CH:14]=[CH:13][N:12]=1

참가 물질

3

반응물 2

HCID 71277823-(2-Methyl-1,3-thiazol-4-yl)benzaldehydeHCID 69082421Methyl 5-amino-5-(2,4-dimethoxypyridin-3-yl)pentanoate

생성물 1

HCID 690854506-(2,4-Dimethoxypyridin-3-yl)-1-(3-(2-methylthiazol-4-yl)benzyl)piperidin-2-one

실험 절차

Prepared according to the described general procedure 1 (GP1) by reaction of methyl 5-amino-5-(2,4-dimethoxypyridin-3-yl)pentanoate with commercially available 3-(2-methylthiazol-4-yl)benzaldehyde. Subsequent purification by preparative HPLC afforded the target compound. LC-MS (conditions A): tR=0.71 min.; [M+H]+: 423.95 g/mol.

후처리

  1. customPrepared
  2. customSubsequent purification by preparative HPLC
  3. customafforded the target compound

출처 및 근거

ORD 기록
ord-c1aaf1bfdc4647f6aeb2eb17a25c6513
출처 데이터셋
uspto-grants-2016_01
특허 번호
US09242970B2

반응 노트

불러오는 중…